Trademark: VCTX212
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for VCTX212
We do not have any records of a proof of use for VCTX212 at this moment.
Possible trademark infringements of VCTX212
Basic Information about VCTX212
- Serial Number
- 97461144
- Filing Date
- 16 Jun 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of VCTX212 on the blockchain with WikiTrademarks.io.
- First use of VCTX212 anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of VCTX212 anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns VCTX212?
1. CRISPR Therapeutics AG ZUG V8 SWITZERLAND
2. CRISPR Therapeutics AG ZUG V8 SWITZERLAND
Correspondent
- Tiffany D. Gehrke MARSHALL, GERSTEIN & BORUN LLP
- 233 SOUTH WACKER DRIVE
- 6300 WILLIS TOWER
- CHICAGO, IL 60606
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io